Edition:
United States

Guided Therapeutics Inc (GTHP.OB)

GTHP.OB on OTC BB

0.40USD
20 Jan 2017
Change (% chg)

$-0.02 (-4.29%)
Prev Close
$0.42
Open
$0.42
Day's High
$0.42
Day's Low
$0.40
Volume
19,785
Avg. Vol
18,503
52-wk High
$1,352.00
52-wk Low
$0.02

GTHP.OB

Chart for GTHP.OB

About

Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices. The Company's primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including... (more)
No analyst recommendations are available for GTHP.OB.

Overall

Beta: 0.60
Market Cap(Mil.): $0.23
Shares Outstanding(Mil.): 0.57
Dividend: --
Yield (%): --

Financials

  GTHP.OB Industry Sector
P/E (TTM): -- 59.99 30.38
EPS (TTM): -1,234.45 -- --
ROI: -- 7.20 14.86
ROE: -- 10.77 16.28

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $62.53 +2.20
GlaxoSmithKline plc (GSK.L) 1,546.50 -6.50
Hologic, Inc. (HOLX.OQ) $39.35 -0.25
Qiagen NV (QGEN.OQ) $27.64 -0.05
SpectraScience Inc (SCIE.PK) $0.00 +0.00

Earnings vs. Estimates

No consensus analysis data available.